DIANE QUINTANA: Open Payments
NPI 1104430982 · EL PASO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,211 in 195 payments from 15 companies in 2025. Trend: 2023 $687 · 2024 $2,965 · 2025 $4,211
Food & beverage: $3,611Speaker / faculty: $600
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 38 | $1,186 |
| Otsuka America Pharmaceutical, Inc. | 26 | $426 |
| Alkermes, Inc. | 32 | $398 |
| E.R. Squibb & Sons, L.L.C. | 15 | $382 |
| Corium, LLC | 18 | $380 |
| Axsome Therapeutics, Inc. | 14 | $307 |
| Teva Pharmaceuticals USA, Inc. | 13 | $238 |
| Supernus Pharmaceuticals, Inc. | 5 | $210 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $200 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $198 |
Products named: VRAYLAR, REXULTI, COBENFY, Azstarys, ARISTADA, Auvelity, Qelbree, TRINTELLIX.
Industry payments across TX — which companies pay providers there.
